Cintas Files Definitive Proxy/Prospectus for $5.5 Billion UniFirst Acquisition
summarizeSummary
Cintas Corporation filed a definitive proxy statement/prospectus (Form 424B3) detailing its $5.5 billion acquisition of UniFirst Corporation, which involves a cash and stock consideration and will result in approximately 3.4% dilution for existing Cintas shareholders.
check_boxKey Events
-
Definitive Merger Terms Finalized
The filing finalizes the terms for the acquisition of UniFirst Corporation, with each UniFirst share to receive $155.00 in cash and 0.7720 shares of Cintas common stock.
-
Share Issuance and Dilution
Cintas will issue approximately 14,261,683 shares of its common stock to UniFirst shareholders, resulting in approximately 3.4% dilution for existing Cintas shareholders.
-
Acquisition Financing Detailed
Cintas plans to fund the cash portion of the acquisition with $2.8 billion in new permanent debt financing, replacing a previously committed bridge facility.
-
UniFirst Shareholder Vote Scheduled
UniFirst shareholders will vote on the merger on June 11, 2026. The controlling Croatti family, holding approximately 67.20% of the combined voting power, has agreed to vote in favor of the merger.
auto_awesomeAnalysis
This 424B3 filing is the definitive proxy statement/prospectus for Cintas Corporation's previously announced $5.5 billion acquisition of UniFirst Corporation. It provides comprehensive details for UniFirst shareholders to vote on the merger, including the specific cash and stock consideration. The transaction involves Cintas issuing approximately 14.26 million shares, resulting in about 3.4% dilution for existing Cintas shareholders, and will be partly funded by $2.8 billion in new debt. The controlling UniFirst family's commitment to vote in favor significantly de-risks the shareholder approval process, making the completion of this strategic expansion highly probable.
At the time of this filing, CTAS was trading at $168.11 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $66.8B. The 52-week trading range was $165.46 to $229.24. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.